![COVID: EVUSHELD antibody treatment soon - Khairy COVID: EVUSHELD antibody treatment soon - Khairy](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-06/41654690954_KhairyJamaludin.jpg)
COVID: EVUSHELD antibody treatment soon - Khairy
The MOH will start administering treatment with the Tixagevimab and Cilgavimab (EVUSHELD) in the near future to ensure that high-risk groups continue to be protected from COVID-19 infection.
Wed Jun 08 2022
![Ubat antibodi Evusheld dimulakan dalam masa terdekat, lindungi golongan berisiko tinggi - Khairy Ubat antibodi Evusheld dimulakan dalam masa terdekat, lindungi golongan berisiko tinggi - Khairy](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-06/81654583269_TBKJ.jpg)
Ubat antibodi Evusheld dimulakan dalam masa terdekat, lindungi golongan berisiko tinggi - Khairy
Mengulas lanjut, Khairy berkata penilaian kelayakan pesakit untuk menerima ubat antibodi tersebut akan dilakukan oleh pakar perubatan yang merawat.
Wed Jun 08 2022
![KKM lulus pendaftaran bersyarat Evusheld, cegah jangkitan COVID-19 KKM lulus pendaftaran bersyarat Evusheld, cegah jangkitan COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-05/51651484877_KetuaPengarahKesih.jpg)
KKM lulus pendaftaran bersyarat Evusheld, cegah jangkitan COVID-19
Ia digunakan berikutan pra-pendedahan COVID-19 kepada orang dewasa dan remaja dengan berat sekurang-kurangnya 40 kilogram.
Thu May 12 2022
![COVID-19: Britain luluskan rawatan berasaskan terapi antibodi COVID-19: Britain luluskan rawatan berasaskan terapi antibodi](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-03/81647563977_Evusheld.jpg)
COVID-19: Britain luluskan rawatan berasaskan terapi antibodi
Ini merupakan usaha terbaharu dalam memerangi pandemik COVID-19 pada ketika peningkatan kes global secara drastik.
Fri Mar 18 2022
![AstraZeneca COVID-19 antibody drug offers 83% protection over six months AstraZeneca COVID-19 antibody drug offers 83% protection over six months](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-09/71632796213_AstraZenecasthera.jpg)
AstraZeneca COVID-19 antibody drug offers 83% protection over six months
These new data add to the growing body of evidence supporting AZD7442's potential to make a significant difference in the prevention and treatment of COVID-19
Thu Nov 18 2021